Hypera S.A. (OTCMKTS:HYPMY) Sees Large Increase in Short Interest

Hypera S.A. (OTCMKTS:HYPMY) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 14,900 shares, an increase of 28.4% from the November 30th total of 11,600 shares. Based on an average daily trading volume, of 50,400 shares, the days-to-cover ratio is currently 0.3 days.

Hypera Stock Up 4.1 %

Shares of HYPMY stock opened at $3.00 on Tuesday. The business has a 50-day moving average price of $3.48 and a two-hundred day moving average price of $4.57. Hypera has a 12-month low of $2.64 and a 12-month high of $7.55. The firm has a market cap of $1.90 billion, a P/E ratio of 5.29 and a beta of 1.02.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.